Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sagwa, Evans L"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sagwa, Evans L.1 esagwa@gmail.com, Ruswa, Nunurai2, Mavhunga, Farai2, Rennie, Timothy3, Leufkens, Hubert G. M.1,4, Mantel-Teeuwisse, Aukje K.1
Publikováno v:
Patient Preference & Adherence. Nov2016, Vol. 10, p2369-2377. 9p.
Publikováno v:
Journal of Pharmaceutical Policy & Practice. 2014, Vol. 7 Issue 10, p7-14. 8p.
Autor:
Sagwa, Evans L, Souverein, Patrick C, Ribeiro, Inês, Leufkens, Hubert G M, Mantel-Teeuwisse, Aukje K
PURPOSE: To evaluate the association between the use of streptomycin, amikacin, kanamycin and capreomycin in tuberculosis (TB) treatment and the pharmacovigilance reporting of ototoxicity (deafness or hearing loss, tinnitus and vertigo). Second, to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::c1a358fd223ab80fc2420a3cdcb6b6bc
https://dspace.library.uu.nl/handle/1874/356214
https://dspace.library.uu.nl/handle/1874/356214
Autor:
Sagwa, Evans L, Ruswa, Nunurai, Mavhunga, Farai, Rennie, Timothy, Leufkens, Hubert G M, Mantel-Teeuwisse, Aukje K, Sub Gen. Pharmacoepi and Clinical Pharm, Sub Pharmacoepidemiology, Sub Pharmacotherapy, Theoretical, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
BMC Pharmacology & Toxicology
BMC pharmacology & toxicology, 16(36). BioMed Central
BMC pharmacology & toxicology, 16(36). BioMed Central
Background Amikacin and kanamycin are mainly used for treating multidrug-resistant tuberculosis (MDR-TB), especially in developing countries where the burden of MDR-TB is highest. Their protracted use in MDR-TB treatment is known to cause dose-depend
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sagwa, Evans L., Souverein, Patrick C., Ribeiro, Inês, Leufkens, Hubert G. M., Mantel ‐ Teeuwisse, Aukje K.
Publikováno v:
Pharmacoepidemiology & Drug Safety; Jan2017, Vol. 26 Issue 1, p1-8, 8p
Autor:
Sagwa, Evans L., Ruswa, Nunurai, Mavhunga, Farai, Rennie, Timothy, Leufkens, Hubert G. M., Mantel-Teeuwisse, Aukje K.
Publikováno v:
BMC Pharmacology & Toxicology; 12/10/2015, Vol. 16, p1-9, 9p
Autor:
Sagwa, Evans Luvaha
Magister Public Health - MPH
Namibia is currently coping with a dual burden of human immunodeficiency (HIV) and HIV-associated tuberculosis (TB). In 2010, HIV prevalence was 18.8%, the TB case notification rate was 634 per 100,000 population, wh
Namibia is currently coping with a dual burden of human immunodeficiency (HIV) and HIV-associated tuberculosis (TB). In 2010, HIV prevalence was 18.8%, the TB case notification rate was 634 per 100,000 population, wh
Externí odkaz:
http://hdl.handle.net/11394/4625